论文信息 - Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study Group. - 字舞流文

Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study Group.

R. Gelber | A. Goldhirsch | A. Coates | M. Castiglione‐Gertsch | A. O'neill

[1] Michael Baum,et al. Polychemotherapy for early breast cancer , 1998, The Lancet.

[2] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[3] R. Collins,et al. Ovarian ablation in early breast cancer: overview of the randomised trials , 1996, The Lancet.

[4] Anthony Howell,et al. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[5] M. Williams,et al. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer. , 1986, British Journal of Cancer.

[6] G. Bonadonna,et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. , 1976, The New England journal of medicine.